Skip to main content
MLSS logo

MLSS · Milestone Scientific Inc.

Track MLSS — free
$0.31 +0.02 (+5.86%) At close · Nov 13
Market Cap
$27.82M
Shares
90.61M
Volume · Nov 13 146.28K Avg daily vol (3M) 104.25K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.31 Open$0.29 Day$0.29–0.32 52W close$0.25–0.55 Avg vol 30d103K Short int79K · 0.1% of shares · 1.0d Short vol31% Last earningsNov 13, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 13

Up next

Mar 30, 2027 Est · unconfirmed · in 19 wks

Latest documents

2026
Nov 13
Earnings call
Targets fourth-quarter 2026 profitability despite $748,000 net loss

Milestone Scientific reported third-quarter revenue of $2.2 million and a $748,000 net loss, but expects to approach or achieve profitability in the fourth quarter of 2026, supported by approximately $400,000 in additional annual savings.

4 source passages
Milestone Scientific, Inc. 3rd Quarter, 2026 Financial Results and Business Update Conference Call. Total revenue was $2.2 million as expected, a modest sequential decline following the two large international orders that benefited our second quarter. Net loss narrowed to $748,000 from $1.2 million a year ago. And just as importantly, our team identified approximately $400,000 in additional annual savings, which we believe supports our expectation to approach or achieve profitability in the fourth quarter of 2026. Open the document at this passage
Nov 13
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Going-concern doubt persists after $2.15 million private placement

Milestone Scientific Inc. reported substantial doubt about continuing as a going concern due to recurring losses and approximately $1.3 million in cash as of September 30, 2026, despite an April 20, 2026 private placement generating approximately $2.15 million.

Revenue $2.22M ▼ 5.9% Net loss $747.55K Diluted EPS -$0.01
Read from the first part of this long document
4 source passages
Milestone Scientific Inc. The Company has incurred recurring losses from operations and negative cash flows from operating activities and had an accumulated deficit of approximately $136.0 million as of September 30, 2026. As of September 30, 2026, the Company had cash and cash equivalents of approximately $1.3 million and working capital of approximately $3.5 million. On April 20, 2026, the Company completed a private placement of 7,962,963 units at a purchase price of $0.27 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock (the “Private Placement”). The transaction generated gross proceeds of approximately $2.15 million, consisting of approximately $1.80 million in cash and approximately $351,000 of outstanding convertible note principal applied toward the purchase of units in lieu of cash, before transaction expenses. Open the document at this passage
Aug 13
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $2.84M ▲ 22.3% Net loss $1.06M Diluted EPS -$0.01
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$9.28M
Trailing 12 months
Net income (TTM)
−$3.56M
Trailing 12 months
Revenue growth YoY
-5.9%
Year over year
Operating margin
-40.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-5.3%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.20M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+14.1%
Year over year · more shares
Price change (1Y)
-19.2%
Trailing year
Short interest
0.1%
Latest settlement · 1.0 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Bullish Fundamentals Weak Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −14%
below
Price vs 50-day avg −15%
below
RSI (14) 45
neutral
MACD trend Positive
52-week position 19%
mid-range
Momentum
relative strength
Weak
1-month return −6%
trailing
6-month return −17%
trailing
YTD return +14%
this year
Relative strength −18%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Accumulating
28 of 29 funds reported for Sep 30 · net +257.3K sh shares · +4 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.09% of shares out · ▼ -3.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
29 holders — near 3-yr low, contrarian setup
Squeeze score 35
low risk · 0–100
Fundamentals
Weak
Revenue growth +4%
Y/Y
Gross margin 71%
contracting
EPS growth −17%
Y/Y
Free cash flow $-2.9M
Quant / Vol
risk profile
Very High
Volatility 81%
annualized · 1-yr
Max drawdown −47%
past year
ATR 10.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 13, 2026
annual
Additional annual savings $400,000
2026
2026 outlook Maintained $9.8M – $10.2M
Mar 31, 2026 $9.8M – $10.2M changed to Nov 13, 2026 $9.8M – $10.2M
prior FY $8.97M midpoint +11.4% Y/Y
moving forward
Gross margin 69% – 70%
Previous outlook earlier release · from the Earnings Call filed Dec 31, 2025

Still-open targets the latest release did not restate under the same label.

CompuFlo revenue · 2026 $500,000 – $600,000

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−14% Bearish
Price vs 50-day avg
−15% Bearish
RSI (14)
45 Neutral
MACD trend
Positive Bullish
52-week position
19% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $0 — 50d above 200d
Institutional flow Accumulating
28 of 29 funds reported for Sep 30 · net +257.3K sh shares · +4 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.09% of shares out · ▼ -3.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
29 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $0 · 19% Range high $1
vs 200-day avg -14% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MLSS
Milestone Scientific Inc.
this stock
$27.82M +13.7% +4.0% — 0.1%
ISRG
Intuitive Surgical Inc
$153.77B -21.7% +20.5% 53.8 2.0%
BDX
Becton Dickinson & Co
$59.39B — +8.2% 96.5 3.0%
MDLN
Medline Inc.
$51.92B -6.0% +11.5% — 2.9%
ALC
Alcon Inc
$35.61B -6.0% +10.5% — 3.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
30
% held
5.5%
Reported
28 of 29
Top holder
VANGUARD CAPITAL MANAGEME…
Held Float
View
Held by Funds
Fund positions
7
View
Short & Settlement
Short Interest Falling
Shares short
78.8K
Days to cover
1.0d
Change
-2.5K sh
View
Short Volume
Short vol %
31%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
172
Value
$58
As of
Oct 14, 2026
View
Off-Exchange
Off-exchange %
69.2%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-5.7M
EPS diluted
$-0.07
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 13, 2026
This year
20

Milestone Scientific Inc. reported substantial doubt about continuing as a going concern due to recurring losses and approximately $1.3 million in cash as of September 30, 2026, despite an April 20, 2026 private placement generating approximately $2.15 million.

View
Proposed Sales
Value
$236.0K
Shares
400.0K
Filed
Sep 9, 2025
View
Exempt Offerings
Offering
$4.8M
Filed
Apr 23, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 13, 2026
View
Investor Relations
Latest news
Milestone Scientific Reports Fina…
Published
Nov 13, 2026
View

Performance

5D 20D 120D MTD YTD
MLSS +1.7% -6.0% -17.0% +0.8% +13.7%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -0.9% -4.8% -17.5% +1.0% +3.1%
Key facts CIK 855683 CUSIP 59935P209 13F (30d) 25 filings 24 filers Visit website Investor relations